Nanomedicines as cancer therapeutics: current status S Akhter, I Ahmad, MZ Ahmad, F Ramazani, A Singh, Z Rahman, ... Current cancer drug targets 13 (4), 362-378, 2013 | 162 | 2013 |
Nanocarrier based formulation of Thymoquinone improves oral delivery: stability assessment, in vitro and in vivo studies A Singh, I Ahmad, S Akhter, GK Jain, Z Iqbal, S Talegaonkar, FJ Ahmad Colloids and Surfaces B: Biointerfaces 102, 822-832, 2013 | 125 | 2013 |
Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern S Akhter, M Zaki Ahmad, A Singh, I Ahmad, M Rahman, M Anwar, ... Current pharmaceutical design 17 (18), 1834-1850, 2011 | 107 | 2011 |
In vitro and in vivo evaluation of Assam Bora rice starch-based bioadhesive microsphere as a drug carrier for colon targeting MZ Ahmad, S Akhter, I Ahmad, A Singh, M Anwar, M Shamim, FJ Ahmad Expert opinion on drug delivery 9 (2), 141-149, 2012 | 63 | 2012 |
A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics A Singh, I Ahmad, S Ahmad, Z Iqbal, FJ Ahmad Drug Development and Industrial Pharmacy 42 (9), 1524-1536, 2016 | 23 | 2016 |
Thymoquinone: major molecular targets, prominent pharmacological actions and drug delivery concerns A Singh, I Ahmad, S Akhter, M Zaki Ahmad, Z Iqbal, F J Ahmad Current Bioactive Compounds 8 (4), 334-344, 2012 | 19 | 2012 |
Prognostic significance of HER-2 and p53 expression in gallbladder carcinoma in north Indian patients A Singh, PK Mishra, SS Saluja, MA Talikoti, P Kirtani, AK Najmi Oncology 91 (6), 354-360, 2016 | 16 | 2016 |
Feasibility of Assam Bora rice starch as a compression coat of 5-fluorouracil core tablet for colorectal cancer M Zaki Ahmad, S Akhter, M Anwar, A Singh, I Ahmad, M Ruhal Ain, ... Current drug delivery 9 (1), 105-110, 2012 | 13 | 2012 |
Phytochemical Nanomodification: Impending Perspectives A Singh ofNext Generation Sequencing & Applications 2 (2), 118, 2015 | | 2015 |